July 5 - 9, join researchers from around the world to explore genome graphs, pangenomics, and metagenomics, including a dedicated Human Pangenome Project session with keynotes from speakers of varied specializations.
Registration open now!
iggsy.org
July 5 - 9, join researchers from around the world to explore genome graphs, pangenomics, and metagenomics, including a dedicated Human Pangenome Project session with keynotes from speakers of varied specializations.
Registration open now!
iggsy.org
Uncover the science behind it: www.cell.com/stem-cell-re...
Uncover the science behind it: www.cell.com/stem-cell-re...
Charles Gersbach, PhD, explains how mapping the function of genetic variation is key to unlocking better treatments, from cancer and fibrosis to neurodegeneration and aging.
▶️ youtu.be/R6Q3yavjGDs
Charles Gersbach, PhD, explains how mapping the function of genetic variation is key to unlocking better treatments, from cancer and fibrosis to neurodegeneration and aging.
▶️ youtu.be/R6Q3yavjGDs
Uncover the science behind it: www.medrxiv.org/content/10.1...
Uncover the science behind it: www.medrxiv.org/content/10.1...
Excited to see the impact highlighted in the 2025 Annual Report. 👏🏼
A year of "momentum and connections"!
➡️ zenodo.org/records/1833...
#AnnualReport #GlobalAlliance #FunctionalGenomics #VariantEffect #Community
Excited to see the impact highlighted in the 2025 Annual Report. 👏🏼
A new reference map helps interpret CHD genes and variants.
Uncover the research behind it: www.biorxiv.org/content/10.6...
A new reference map helps interpret CHD genes and variants.
Uncover the research behind it: www.biorxiv.org/content/10.6...
Hear from Jesse Engreitz, PhD, and other IGVF members in the full Q&A.
▶️ youtu.be/zPzGIjSQJ4U
Hear from Jesse Engreitz, PhD, and other IGVF members in the full Q&A.
▶️ youtu.be/zPzGIjSQJ4U
Editing these enhancers can reshape cell behavior, pointing to new therapeutic possibilities.
Read more:
www.science.org/doi/10.1126/...
Editing these enhancers can reshape cell behavior, pointing to new therapeutic possibilities.
Read more:
www.science.org/doi/10.1126/...
As we wrap up 2025 and look toward 2026, we’re excited to share voices from across IGVF.
Tune in to our IGVF Q&A featuring consortium members reflecting on this year’s work and what’s ahead: youtu.be/zPzGIjSQJ4U
As we wrap up 2025 and look toward 2026, we’re excited to share voices from across IGVF.
Tune in to our IGVF Q&A featuring consortium members reflecting on this year’s work and what’s ahead: youtu.be/zPzGIjSQJ4U
Learn more: www.nature.com/articles/s41...
Learn more: www.nature.com/articles/s41...
Explore the tool:
github.com/pachterlab/k...
Explore the tool:
github.com/pachterlab/k...
Use the resource, explore the data, and tell us what you think!
academic.oup.com/nar/advance-...
Use the resource, explore the data, and tell us what you think!
academic.oup.com/nar/advance-...
Congratulations to each of our award recipients 👏🏽
Congratulations to each of our award recipients 👏🏽
Thank you for your collaboration, dedication, and the incredible work you do to advance our understanding of human health and disease.
Thank you for your collaboration, dedication, and the incredible work you do to advance our understanding of human health and disease.
This year’s meeting features several talks from IGVF members, all aligned with our efforts to link genomic variation to function.
Keynote by Douglas Fowler (UW).
Late registration ends Dec 1.
genomeinterpretation.org/cagi7.html
This year’s meeting features several talks from IGVF members, all aligned with our efforts to link genomic variation to function.
Keynote by Douglas Fowler (UW).
Late registration ends Dec 1.
genomeinterpretation.org/cagi7.html
shorturl.at/H3Qww
This is an enormous team effort that I had the honour of spearheading with Nick Page and Florence Chardon.
Bluetorial below.
shorturl.at/H3Qww
This is an enormous team effort that I had the honour of spearheading with Nick Page and Florence Chardon.
Bluetorial below.
A major step forward for scalable CRT discovery, and a significant contribution to understanding gene regulation in human neurons.
We combined MPRA and CRISPRa in excitatory neurons to test and validate cis-regulation therapies for hundreds of haploinsufficient neurodevelopmental disorder genes. 🧬🔬
www.biorxiv.org/content/10.1...
A major step forward for scalable CRT discovery, and a significant contribution to understanding gene regulation in human neurons.
Learn more & access the tool here: github.com/EngreitzLab/...
Learn more & access the tool here: github.com/EngreitzLab/...
Learn more about our work at www.igvf.org
Learn more about our work at www.igvf.org
Whether you’re celebrating or just enjoying a well-earned weekend, we hope it’s a wickedly wonderful one!
Whether you’re celebrating or just enjoying a well-earned weekend, we hope it’s a wickedly wonderful one!
Using CRISPR knockout screens and single-cell RNA-seq, researchers identified key host factors and responses that drive infection.
Read more: pmc.ncbi.nlm.nih.gov
Using CRISPR knockout screens and single-cell RNA-seq, researchers identified key host factors and responses that drive infection.
Read more: pmc.ncbi.nlm.nih.gov
A huge thank you to the Durham Bulls Athletic Park for welcoming us and hosting a fantastic night of food, fun, and practice home runs! ⚾
A huge thank you to the Durham Bulls Athletic Park for welcoming us and hosting a fantastic night of food, fun, and practice home runs! ⚾
With MultiVINE-seq, researchers mapped thousands of risk variants, revealing distinct mechanisms for cerebrovascular vs. neurodegenerative disorders—including Alzheimer’s.
www.cell.com/neuron/fullt...
With MultiVINE-seq, researchers mapped thousands of risk variants, revealing distinct mechanisms for cerebrovascular vs. neurodegenerative disorders—including Alzheimer’s.
www.cell.com/neuron/fullt...
A recent study introduces PerturbNet, a deep generative model that predicts how unseen drugs, CRISPR edits, or even missense mutations alter single-cell gene expression.
Read the full publication:
pmc.ncbi.nlm.nih.gov/articles/PMC...
A recent study introduces PerturbNet, a deep generative model that predicts how unseen drugs, CRISPR edits, or even missense mutations alter single-cell gene expression.
Read the full publication:
pmc.ncbi.nlm.nih.gov/articles/PMC...